A fully automated synthesis for the preparation of 68Ga-labelled peptides
- 1 November 2007
- journal article
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 28 (11) , 870-875
- https://doi.org/10.1097/mnm.0b013e3282f1753d
Abstract
Generator-produced Ga has attracted increasing interest for radiolabelling peptides used in PET applications. So far, the synthesis of Ga-peptide radiopharmaceuticals is mainly based on semi-automated systems. Here we describe a fully automated approach for the synthesis of Ga-labelled peptides. A commercially available Ga generator was eluted with 0.1 mol . l HCl. Reaction parameters such as buffer conditions, pH range, reaction temperature and time, volume of reaction solution and generator fraction were optimized for labelling DOTA-Tyr-octreotide (DOTATOC). Reaction yields, pH, radiochemical purity, sterility, endotoxins, breakthrough of Ge and final Ge content were determined. A fully automated radiopharmaceutical synthesis device based on a modular concept for remote-controlled processing was developed and evaluated for a number of DOTA-derivatized peptides. DOTATOC could be labelled in almost quantitative yields by heating 10-50 nmol peptide at pH 3.5-4.0 for 5 min at 95 degrees C in 1.5 ml. Purification using a reversed-phase cartridge was required to avoid any potential Ge breakthrough: final activities of Ge were below 100 Bq . ml. Automated synthesis resulted in overall decay-corrected reaction yields of about 60% within 10 min. Even after 1 year using a 1110 MBq generator more than 130 MBq Ga-DOTATOC could be obtained. Moreover, it was demonstrated that a variety of DOTA-derivatized peptides can be labelled using identical reaction conditions with high yields. The system described allows the fully automated, efficient and rapid preparation of Ga-DOTA-derivatized peptides. It has been used successfully and reliably for routine preparations in clinical studies.Keywords
This publication has 7 references indexed in Scilit:
- 68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CTJournal of Nuclear Medicine, 2007
- The 68Ge/68Ga generator has high potential, but when can we use 68Ga-labelled tracers in clinical routine?European Journal of Nuclear Medicine and Molecular Imaging, 2007
- Infrared-based module for the synthesis of 68Ga-labeled radiotracersNuclear Medicine and Biology, 2007
- Radiolabelling DOTA-peptides with 68GaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2005
- Microwave-Supported Preparation of 68Ga Bioconjugates with High Specific RadioactivityBioconjugate Chemistry, 2004
- 68Ga-labelled DOTA-derivatised peptide ligandsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004
- Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary dataEuropean Journal of Nuclear Medicine and Molecular Imaging, 2001